Home › Funds › Two Sigma Investments › CTMX
Two Sigma Investments position in CTMX
CYTOMX THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)4.13M sh
Reported value held$15.50M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 101.85K | $518.00K | New |
| Q4 2021 | 184.97K | $801.00K | Add |
| Q1 2022 | 491.78K | $1.31M | Add |
| Q2 2022 | 297.88K | $545.00K | Reduce |
| Q3 2022 | 357.96K | $519.00K | Add |
| Q4 2022 | 740.72K | $1.19M | Add |
| Q1 2023 | 467.62K | $706.10K | Reduce |
| Q2 2023 | 138.45K | $238.13K | Reduce |
| Q3 2023 | 50.09K | $64.62K | Reduce |
| Q4 2023 | 14.14K | $21.92K | Reduce |
| Q1 2024 | 253.77K | $553.23K | Add |
| Q2 2024 | 661.95K | $807.58K | Add |
| Q3 2024 | 471.47K | $556.33K | Reduce |
| Q4 2024 | 320.77K | $330.39K | Reduce |
| Q1 2025 | 116.47K | $74.06K | Reduce |
| Q2 2025 | 157.68K | $357.94K | Add |
| Q3 2025 | 729.70K | $2.33M | Add |
| Q4 2025 | 1.56M | $6.65M | Add |
| Q1 2026 | 2.71M | $12.74M | Add |
| Q2 2026 | 4.13M | $15.50M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTMX
- Fidelity Management & Research (FMR) 32.71M sh · $122.68M · Q2 2026
- BlackRock Inc 17.56M sh · $65.85M · Q2 2026
- Bank of America Corp 15.08M sh · $56.56M · Q2 2026
- Vanguard Group 8.48M sh · $36.11M · Q4 2025
- Point72 Asset Management 7.81M sh · $29.29M · Q2 2026
- Wellington Management Group 5.17M sh · $19.38M · Q2 2026
- Geode Capital Management 4.68M sh · $17.55M · Q2 2026
- UBS Group AG 3.47M sh · $13.01M · Q2 2026
- Citadel Advisors 3.33M sh · $12.49M · Q2 2026
- Marshall Wace 3.02M sh · $11.34M · Q2 2026
- Goldman Sachs Group 2.00M sh · $7.51M · Q2 2026